SAN DIEGO, Nov. 28 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc., a biopharmaceutical company focused on neurological and endocrine diseases and disorders announced today that Gary Lyons, President and CEO will present at the CIBC World Markets ‘Best Ideas’ Small and Mid Cap Conference tomorrow, Tuesday, November 29, 2005 at the Millennium Broadway Hotel in New York.
The live presentation begins at 11:00am Eastern Time (ET) / 8:00am Pacific Time (PT) and will include an update on the Company’s broad development pipeline and research programs. The presentation will be webcast and can be accessed on the Company’s website at http://www.neurocrine.com.
A replay of the webcast will be available approximately three hours after the presentation concludes and will be archived until Tuesday, December 13, 2005. Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.
If you are unable to attend the webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600 and ask for Claudia Woodworth or Elizabeth Foster.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, and autoimmunity. Neurocrine Biosciences, Inc. news releases are available through the Company’s website via the Internet at http://www.neurocrine.com
Contact: Claudia Woodworth or Elizabeth Foster at 858-617-7600.
Neurocrine Biosciences, Inc.
CONTACT: Investors, Claudia Woodworth or Elizabeth Foster, both ofNeurocrine Biosciences, Inc., +1-858-617-7600
Web site: http://www.neurocrine.com/
